BSE Issues Trading Alert: Price Bands Revised For 27 Stocks, Effective April 30

BSE Issues Trading Alert: Price Bands Revised For 27 Stocks, Effective April 30

BSE has revised the price bands of 27 scrips, mostly to 2 per cent, effective April 30, 2025. Quess Corp stands out with a 20 per cent band. Traders should note the changes and seek clarification if needed.

Manoj YadavUpdated: Wednesday, April 30, 2025, 10:26 AM IST
article-image
BSE Updates Price Band Limits |

Mumbai: The Bombay Stock Exchange (BSE) has announced revisions in the price bands of 27 listed companies, which will come into effect from April 30, 2025. This move is part of the exchange's routine market surveillance and volatility control measures.

Majority of Stocks Set at 2 per cent Band

Out of the 27 scrips, 24 will now trade within a 2 per cent daily price band. Some of the prominent names affected include Aerpace Industries Ltd (Scrip Code: 534733), Best Agrolife Ltd (539660), and Quess Corp Ltd (539978). Notably, Quess Corp has been assigned a significantly higher price band of 20 per cent.

Select Stocks Get 5 per cent Revision

Fermenta Biotech Ltd (506414) and Vivid Mercantile Ltd (542046) have had their price bands revised to 5 per cent. These changes are likely driven by recent market behavior and liquidity considerations in these counters.

Clarification and Queries

Trading members are advised to take note of the changes and may reach out to the exchange via bse.surv@bseindia.com for further clarification.

RECENT STORIES

Gensol Engineering Hits 15th Straight Lower Circuit, Down 93% From Peak Amid SEBI Probe

Gensol Engineering Hits 15th Straight Lower Circuit, Down 93% From Peak Amid SEBI Probe

India's Gold Prices Rise 25%; Demand To Be Between 700-800 Tonnes

India's Gold Prices Rise 25%; Demand To Be Between 700-800 Tonnes

SEBI Delays T+0 Rule For Big Brokers, New Start Date Is November 1, 2025

SEBI Delays T+0 Rule For Big Brokers, New Start Date Is November 1, 2025

USFDA Grants Approval To Zydus Lifesciences: Can Manufacture Niacin Tablets

USFDA Grants Approval To Zydus Lifesciences: Can Manufacture Niacin Tablets

India’s BEV Sales Surge As Government Incentives And New Models Drive EV Momentum In 2024

India’s BEV Sales Surge As Government Incentives And New Models Drive EV Momentum In 2024